The Trust and data company have agreed to use patient data to support the development of precision medicines.
Leeds Teaching Hospitals NHS Trust has signed a multi-year strategic partnership with Oxford-based Arcturis, which uses multi-modal data to support the development of precision medicines.
This agreement will see the Trust provide comprehensive, real-time access to diverse and enriched health data that is geographical representative of the UK population.
“By combining our clinical expertise with Arcturis’ data science and analytic capabilities, this partnership has the opportunity to accelerate the development of new therapies and improve patient outcomes,” said Paul Jones, chief digital information officer at the Trust.
This partnership will bring Leeds Teaching Hospitals clinical expertise and specialism across a range of therapeutic areas including cardiology, neurology and oncology into the Arcturis network.
The Arcturis network has been approved by the Health Research Authority, the NHS ethics body, and is designed for diverse types of real-world data including medications, laboratory tests, pathology reports, clinical notes and unstructured data into standardised, disease-specific datasets.
These datasets are then used to generate precision data insights that support activities across the drug development pathway including clinical trials, regulatory submissions and post-authorisation safety studies.
All insights generated use anonymised patient data.
